Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 • 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

October 21, 2022 • 00:18:32
Episode Cover

Does the Timing of Source Control in Sepsis Make a Difference?

The emergency department resuscitation of patients with sepsis focuses on early recognition, timely administration of appropriate antibiotics, appropriate fluid resuscitation, early vasopressor initiation for...

Listen

Episode 0

October 23, 2019 • 00:19:35
Episode Cover

TTM For Nonshockable Rhythms?

Current guidelines for post-cardiac arrest management recommend TTM (32C to 36C) for all patients with coma after resuscitation from cardiac arrest. The benefit of...

Listen

Episode 0

November 25, 2018 • 00:22:59
Episode Cover

The Post-Cardiac Surgery Patient in Your ED!

More than 200,000 patients per year undergo coronary artery bypass graft (CABG) surgery. Up to 20 percent of these patients will require readmission within...

Listen